Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi Feels The Weight Of FDA’s “Approvable” Letter For Rimonabant

Related Content

Sanofi-Aventis To Begin Long-Term Acomplia Cardio Safety Study By Fall

Mar 28 2005

Acomplia Pricing Likely To Follow Statin Model, Sanofi Says

Sep 06 2004

Sanofi-Aventis Expects Broad Label For Acomplia After FDA Obesity Panel

Sep 27 2004

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window